Introduction
Women living with HIV (WLWH) have a substantially higher risk of persistent high-risk human papillomavirus (HPV) cervical infections [1] [2] [3] [4] and to develop cervical intraepithelial neoplasia grade 2, grade 3, adenocarcinoma in situ or invasive cancer (CIN2þ) than HIV-negative women (HNW) [5] [6] [7] [8] . In addition, treatment failure and recurrence of cervical lesions after surgical treatment of CIN2þ seem to be more common in WLWH than in HNW [9, 10] . Although a recent meta-analysis indicates that antiretroviral therapy (ART) is associated with reduction of the incidence and progression of cervical lesions [11] , it is yet uncertain what role ART plays regarding outcome after treatment of CIN2þ [12] [13] [14] [15] . Earlier studies have often been based on self-reported ART-use with no access to HIV-RNA levels as a measure of effective ART [9, 10, 12, 15] . We conducted a country of birth matched population-based cohort study with the aim of analyzing if WLWH have poorer outcome after treatment of CIN2þ than HNW and to identify predictors of CIN2þ treatment failure and recurrence in WLWH.
Methods
Study design, participants and data sources We used the unique national registration number assigned to all individuals in Sweden at birth or on immigration to link the Swedish National HIV Registry and the Swedish Population Registry (SPR) with the Swedish National Cervical Screening Registry.
Swedish National HIV Registry (InfCare HIV) All WLWH, born between 1942 and 1989, living in the counties of Stockholm and Gothenburg sometime between 1983 and 2014, were identified from InfCare HIV (n ¼ 1926, Fig. 1 ). This registry includes more than 99% of Swedish residents diagnosed with HIV [16] . Patients are consecutively enrolled to the registry at time of HIV diagnosis and demographic, therapeutic and laboratory data are registered at least every 6 months. We extracted data regarding ART, HIV-RNA levels, CD4 þ cell counts, date of HIV-diagnosis, mode of HIVtransmission and country of birth. Approximately 56% of people living with HIV in Sweden live in the counties of Stockholm and Gothenburg.
Swedish Population Registry
All HNW, born between 1942 and 1989, living in the counties of Stockholm and Gothenburg sometime between 1983 and 2014 were identified from the SPR (n ¼ 1189 835, Fig. 1 ). This registry contains all individuals residing in Sweden on a permanent basis. We extracted data on birth, date of immigration, emigration and country of birth.
Swedish National Cervical Screening Registry (NKCx) All WLWH with a diagnosis of CIN2 þ were identified from the NKCx (n ¼ 179, Fig. 1 ). This registry includes all cervical cytology results and histopathology results in Sweden since 1993, irrespective of where screening or colposcopy has taken place [17] . For each WLWH, two HNW, living in the same counties sometime between 1983 and 2014, diagnosed with CIN2þ (n ¼ 96 727), were randomly selected and matched for country of birth (n ¼ 321, Fig. 1 ). For some WLWH, only one or no HNW from the same country of birth could be identified (refer to Supplemental Digital Content Table 1 , http:// links.lww.com/QAD/B275). Women were excluded if they had a hysterectomy performed before start of followup (WLWH n ¼ 3, HNW n ¼ 11) or if they had no follow-up cervical cytology or histology within 1 year of CIN2þ treatment (WLWH n ¼ 36, HNW n ¼ 26) (refer to Supplemental Digital Content Table 2 , http:// links.lww.com/QAD/B275). During the study period, all women living in Sweden were invited to cervical cancer screening every 3 (aged 23-50) to 5 years (aged 51-60) according to national guidelines [18] . WLWH were recommended annual screening. Both WLWH and HNW were, during the study period, recommended cervical cytology every 6 months the 1st year after treatment of CIN2þ and thereafter annually for the subsequent 25 years. Since 2010, HPV-testing has been recommended within 1 year of treatment of CIN2þ [18] . Colposcopy was used when indicated. All cervical cytology and histopathology reports of included women were collected up to 31 December 2015.
Medical records
Medical record reviews were performed to elicit information on mode of treatment of CIN2þ [large loop excision of the transformation zone (equal to loop electrosurgical excision procedure), laser conization, cold knife conisation, cryotherapy or expectancy], radicality of conization (positive endocervical and/or exocervical margins), history of smoking and nativity. Recommendation of surgical treatment of CIN2þ did not differ between WLWH and HNW during the study period [18] . cervical cytology/histology within 1 year and no hysterectomy performed before start of follow-up were included in the final study population (Fig. 1) .
Definition of outcomes
Treatment failure was defined as presence of CIN2þ on cervical cytology/histology at initial follow-up, within 1 year of treatment. In a sensitivity analysis treatment, failure was defined as presence of an abnormal (atypical squamous cells of undetermined significance or worse: ASCUSþ) cervical cytology/histology at initial followup, within 1 year of treatment. Women with normal cervical cytology/histology at follow-up were considered successfully treated and were included in analysis of recurrence, defined as subsequent CIN1þ. These women were followed from date of first follow-up after treatment of CIN2þ until date of recurrence, or if no recurrence took place, until date of last registered cervical cytology/ histology.
Statistical analysis
Continuous data were summarized as median or mean and categorical variables listed as numbers and percentages. Logistic regression analyses were used for estimating the effect of covariates associated with treatment failure in all women (HIV-status, treatment modality, grade of cervical lesion, nativity, positive surgical margins and smoking) and in WLWH only [suppressive ART (HIV-RNA < 50 copies/ml within 6 months of treatment of CIN2þ), CD4 þ cell count within 1 year of treatment of CIN2þ (continuous and stratified), nadir CD4 þ cell count (continuous and stratified), mode of HIV transmission, decade of HIV-diagnosis]. All models were adjusted for age at time of treatment of CIN2þ (continuous variable) and region of birth. Cox regression analyses were used for estimating the effect of covariates associated with recurrence, with the same covariates as mentioned for the logistic regression. Schoenfeldt residual plots were used to ensure that the proportional hazards assumption was not violated. As levels of HIV-RNA and CD4
þ cell count at time of treatment of CIN2þ are highly dependent covariates, they were not used in the same model. Nadir CD4 þ cell count was adjusted for in models including HIV-RNA level or CD4
þ cell count at time of treatment of CIN2þ. Suppressive ART was defined as HIV-RNA less than 50 copies/ml within 6 months of treatment of CIN2þ, but as the lower limit of detection of HIV-RNA was 500 copies/ml in Swedish laboratories until 2004, we performed a sensitivity analysis with suppressive ART defined as HIV-RNA less than 500 copies/ml. In a subanalysis, we compared WLWH with suppressive ART to HNW, and in an additional subanalysis, we compared WLWH with more than 6 months suppressive ART at time of treatment of CIN2þ to those with less than 6 months suppressive ART. A P value less than 0.05 was considered statistically significant. Calculations were done using STATA 13 software (STATA Corp., College Station, Texas, USA). 
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Results
One hundred and forty WLWH and 284 HNW were included in the final study population. Mean age was slightly above 30 (Table 1) . About 70% were migrants, of whom a majority was born in sub-Saharan Africa. Most WLWH had acquired HIV heterosexually (86%) and a majority had at one point been highly immunosuppressed (median nadir CD4 þ cell count 147 cells/ml [interquartile range (IQR) 56-360], Table 2 ). Sixty-five percent were on at least three antiretrovirals at time of treatment of CIN2þ and 53% on suppressive ART.
Treatment failure defined as CIN2R, in all women
Among all participants, 30 (21%) WLWH and 20 (7%) HNW had treatment failure (Table 1) . WLWH were more than three times more likely to have a treatment failure (odds ratio (OR) 3.7 [95% confidence interval (CI) 2.0-6.8], Table 3 ) than HNW. When restricting WLWH to those with suppressive ART at time of treatment of CIN2þ (n ¼ 75), the association decreased and was no longer statistically significant (OR 1.8 [95% CI 0.8-4.2]). Grade of lesion was significantly associated with treatment failure in WLWH only (Table 3) . Treatment modality and nativity were not significantly associated with treatment failure in logistic regression analysis (Table 3) . We were not able to adjust for smoking due to lack of adequate registration in medical records of this variable. Positive surgical endo/exocervical margins at time of treatment were also inadequately registered in medical records.
Treatment failure defined as CIN2R, in women living with HIV only Suppressive ART (HIV-RNA < 50 copies/ml) was associated with reduced OR of treatment failure (OR 0.3 [95% CI 0.1-0.8]) and the association remained after adjusting for nadir CD4 þ cell count (Table 3) . When redefining suppressive ART as HIV-RNA less than 500 copies/ml, the results were similar (OR 0.3 [95% CI 0.1-0.7]). When restricting the analysis to WLWH with suppressive ART at time of treatment of CIN2þ, there was no association between time on suppressive ART (more or less than 6 months) and treatment failure (OR 1.1 [95% CI 0.3-5.3]). There were only nine cases of treatment failure among women with suppressive ART at time of treatment of CIN2þ. Advanced immunosuppression (CD4 þ cell count <200 cells/ml) at time of treatment of CIN2þ was associated with more than eight times higher OR of treatment failure than a CD4
þ cell count at least 500 cells/ml (OR 8.5 [95% CI 2.3-30.7], Table 3 ). Although treatment failure was associated with low median nadir CD4 þ cell count in univariate analysis (Table 2) , CD4 þ nadir less than 200 was not significantly associated with higher OR of treatment failure compared with nadir CD4
þ cell count at least 350 cells/ml (OR 6.5 [95% CI 0.8-53.6]) in multivariate analysis and the association decreased even more when adjusting for CD4
þ cell count at time of treatment in the same model (Table 3) . Earlier decade of HIV-transmission was associated with treatment failure in univariate (Table 2) but not in multivariate analysis (Table 3) . Mode of HIV transmission was not significantly associated with treatment failure (Table 3) .
In a sensitivity analysis, treatment failure was defined as ASCUS or worse. This brought similar results as treatment failure defined as CIN2þ (refer to Supplemental Digital Content Recurrence defined as the presence of CIN1þ subsequent to an initial normal follow-up. Table 3 . Characteristics associated with treatment failure defined as CIN2R at time of first follow-up. Table 3 Table 3 , http://links.lww.com/QAD/B275).
Discussion
In our comprehensive, population-based cohort study with essentially complete follow-up, WLWH had more treatment failure and recurrence, after treatment of CIN2þ, than HNW. Suppressive ART and CD4 þ cell counts above 499 at time of treatment of CIN2þ were associated with effective treatment of CIN2þ. In addition, CD4
þ cell count at time of treatment of CIN2þ seems to be a better predictor of treatment success than nadir CD4 þ cell count.
Suppressive ART was associated with effective treatment of CIN2þ. A majority of studies using only self-reported use of ART as a measure of effective ART have not found an association between ART and successful treatment [9, 10, 12] . In an early smaller study, Robinson et al. [15] found less recurrence (in our study defined as treatment failure) in WLWH on self-reported ART compared with those without, although there was no measure of effect analysis in that study. Reimers et al. [13] did not find an association between HIV-RNA levels and treatment failure. Contrary to our study, both these studies included women treated for CIN1 despite the fact that this is usually a self-healing lesion.
Similar to earlier studies, severe immunosuppression at time of treatment of CIN2þ was associated with treatment failure [9, 10, 13, 19] . A low nadir CD4 þ cell count was not as robustly associated with treatment failure as CD4 þ cell count measured at time of treatment. When adjusting for CD4 þ cell count and nadir CD4 þ cell count in the same model, the association between nadir CD4 þ cell count and treatment failure decreased even more. This may indicate that CD4
þ cell count at time of treatment of CIN2þ is a better predictor of treatment failure than nadir CD4 þ cell count.
Our population based study found more high-grade lesions at time of treatment failure than in a closely followed US prospective cohort [10] , but less than in another US study that included more severely immunosuppressed women and fewer on suppressive ART [13] . It has been suggested that failure after CIN2þ treatment in WLWH mainly represents low-grade lesions due to opportunistic HPV-infections [10] , but this is not supported in our study in which treatment failure was high even when restricted to CIN2þ.
In agreement with earlier studies, WLWH in our study had more treatment failure than HNW [9, 10, 19] . Although grade of initial lesion was significantly associated with treatment failure only for WLWH, this does not explain our results as differences depending on HIV-status remained after adjusting for grade of lesion. Even WLWH with suppressive ART had remaining, though nonsignificant, higher odds of having a treatment failure, than HNW, which may be due to residual chronic immune activation and lack of full restoration of cervical mucosal immunity despite successful inhibition of HIV replication [11, 20] .
WLWH had higher risk of recurrence than HNWand the risk of recurrence increased with diminishing CD4 þ cell count at time of treatment of CIN2þ. It is difficult to compare our results with those from earlier studies as recurrence has often been unclearly defined, more specifically it was often not specified if a normal cytology/histology was found at first follow-up after treatment before inclusion in analysis of recurrence [14, 19, 21] . One US study with access to HIV-RNA levels found an association between high HIV-RNAlevels and an increased risk of recurrence [13] , whereas studies using self-reported ART have found conflicting results [10, 22] . We did not find suppressive ART to be associated with a reduced risk of recurrence, which may have been due to few events in WLWH (n ¼ 13) leading to a lack of precision of this estimate.
Limitations of our study include the inability to adjust for smoking due to inadequate registration of this variable in medical records. Even though smoking is a known risk factor of treatment failure, it is unlikely that confounding by smoking entirely explain our results. Registration of positive surgical margins was also often lacking in medical records in our study. This is also a known risk factor of treatment failure and recurrence, and WLWH have been shown to have positive margins more often than HNW [22, 23] . However, as positive margins are most probably in the causal pathway between immunosuppression and treatment failure (i.e. an intermediate variable), it would not have been correct to adjust for positive margins. We did not have access to HPV status at time of treatment of CIN2þ or at time of treatment failure/recurrence as this has only lately been registered in the screening registry. We did not have access to mode of treatment of CIN2þ for all women, because of lack of information in medical records; therefore, more women than stated may have been treated with expectancy only. Traditionally, WLWH are prone to more aggressive treatment of cervical lesions than HNW, so if anything, this may have led to an underestimation of the odds of treatment failure and risk of recurrence in WLWH. Despite these limitations, our study has several strengths. We have had access to individual data from essentially complete national HIV registry and nationwide registry of cervical cytology and histopathology reports with long-term follow-up, altogether providing high validity.
Conclusion
To our knowledge, this is the first study showing an association between suppressive ART and successful treatment of CIN2þ in WLWH. In countries where the burden of HIV is high and access to regular cervical cancer screening, HPV vaccination and treatment of CIN2þ is poor, it is especially important with early HIV diagnosis, access to ART and continuum of care to reach successful CIN2þ treatment.
